The Cancer System Quality Index supports improvements in the quality and performance of healthcare in Ontario. 

This year, we focus on key hematologic cancer indicators to highlight bright spots and opportunities to improve quality of care for people with acute lymphocytic leukemia, acute myeloid leukemia, diffuse large B-cell lymphoma and multiple myeloma. Data was not updated for this reporting year for the following cancers: breast, colorectal, lung and prostate. 

Next year, we will highlight the impact of COVID-19 on cancer system performance.